Pulmonary Alveolar Hemorrhage after Clopidogrel Use for ST Elevation Myocardial Infarction.
10.4070/kcj.2013.43.7.497
- Author:
Youngjoong KIM
1
;
Joohan LIM
;
Jonggu LIM
;
Soohyun KIM
;
Taeyoung JUNG
;
Woonggil CHOI
Author Information
1. Division of Cardiology, Department of Internal Medicine, Konkuk University College of Medicine, Chungju, Korea. gilll7@kku.ac.kr
- Publication Type:Case Report
- Keywords:
Hemoptysis;
Antiplatelet drugs;
Myocardial infarction
- MeSH:
Aspirin;
Glycoproteins;
Hemoptysis;
Hemorrhage;
Humans;
Myocardial Infarction;
Percutaneous Coronary Intervention;
Platelet Aggregation Inhibitors;
Ticlopidine
- From:Korean Circulation Journal
2013;43(7):497-499
- CountryRepublic of Korea
- Language:English
-
Abstract:
Combination treatment of antiplatelet drugs containing aspirin and clopidogrel reduces systemic ischemic events after percutaneous coronary intervention (PCI) in high risk patients. However, this combination treatment of antiplatelet drugs is associated with increased risk of nonfatal and fatal bleeding. Diffuse alveolar hemorrhage after PCI is a rare complication that has been mostly reported in association with glycoprotein IIb/IIIa inhibitors. We report the case of a 62-year-old man who presented with ST elevation myocardial infarction and suffered a diffuse alveolar hemorrhage after clopidogrel use following primary PCI.
